share_log

Qiagen's (NYSE:QGEN) Investors Will Be Pleased With Their 15% Return Over the Last Five Years

Qiagen's (NYSE:QGEN) Investors Will Be Pleased With Their 15% Return Over the Last Five Years

Qiagen(紐約證券交易所代碼:QGEN)的投資者將對過去五年中15%的回報感到滿意
Simply Wall St ·  05/13 08:33

If you buy and hold a stock for many years, you'd hope to be making a profit. Furthermore, you'd generally like to see the share price rise faster than the market. Unfortunately for shareholders, while the Qiagen N.V. (NYSE:QGEN) share price is up 11% in the last five years, that's less than the market return. The last year has been disappointing, with the stock price down 6.7% in that time.

如果你買入並持有股票多年,你希望獲利。此外,您通常希望看到股價的上漲速度快於市場。對於股東來說,不幸的是,儘管Qiagen N.V.(紐約證券交易所代碼:QGEN)的股價在過去五年中上漲了11%,但仍低於市場回報率。去年令人失望,當時股價下跌了6.7%。

Let's take a look at the underlying fundamentals over the longer term, and see if they've been consistent with shareholders returns.

讓我們來看看長期的基本面,看看它們是否與股東的回報一致。

While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.

儘管一些人繼續教導高效市場假說,但事實證明,市場是反應過度的動態系統,投資者並不總是理性的。通過比較每股收益(EPS)和一段時間內的股價變化,我們可以了解投資者對公司的態度是如何隨着時間的推移而變化的。

Over half a decade, Qiagen managed to grow its earnings per share at 12% a year. The EPS growth is more impressive than the yearly share price gain of 2% over the same period. So one could conclude that the broader market has become more cautious towards the stock.

在過去的五年中,Qiagen設法將其每股收益增長到每年12%。每股收益的增長比同期2%的年度股價增長更令人印象深刻。因此,人們可以得出結論,整個市場對該股變得更加謹慎。

You can see how EPS has changed over time in the image below (click on the chart to see the exact values).

您可以在下圖中看到 EPS 隨時間推移的變化(點擊圖表查看確切值)。

earnings-per-share-growth
NYSE:QGEN Earnings Per Share Growth May 13th 2024
紐約證券交易所:QGEN每股收益增長 2024年5月13日

It's probably worth noting that the CEO is paid less than the median at similar sized companies. It's always worth keeping an eye on CEO pay, but a more important question is whether the company will grow earnings throughout the years. Dive deeper into the earnings by checking this interactive graph of Qiagen's earnings, revenue and cash flow.

可能值得注意的是,首席執行官的薪水低於類似規模公司的中位數。始終值得關注首席執行官的薪酬,但更重要的問題是公司多年來是否會增加收益。查看這張Qiagen收益、收入和現金流的交互式圖表,深入了解收益。

What About The Total Shareholder Return (TSR)?

那麼股東總回報(TSR)呢?

Investors should note that there's a difference between Qiagen's total shareholder return (TSR) and its share price change, which we've covered above. The TSR attempts to capture the value of dividends (as if they were reinvested) as well as any spin-offs or discounted capital raisings offered to shareholders. We note that Qiagen's TSR, at 15% is higher than its share price return of 11%. When you consider it hasn't been paying a dividend, this data suggests shareholders have benefitted from a spin-off, or had the opportunity to acquire attractively priced shares in a discounted capital raising.

投資者應注意,Qiagen的股東總回報率(TSR)與其股價變動之間存在差異,我們在上面已經介紹了這一點。股東總回報率試圖捕捉股息(就好像它們被再投資一樣)以及向股東提供的任何分拆或折扣資本籌集的價值。我們注意到,Qiagen的股東總回報率爲15%,高於其11%的股價回報率。當你考慮到它沒有派發股息時,這些數據表明股東已經從分拆中受益,或者有機會通過折扣融資收購定價誘人的股票。

A Different Perspective

不同的視角

While the broader market gained around 28% in the last year, Qiagen shareholders lost 3.9%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. On the bright side, long term shareholders have made money, with a gain of 3% per year over half a decade. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. If you would like to research Qiagen in more detail then you might want to take a look at whether insiders have been buying or selling shares in the company.

去年整體市場上漲了約28%,而Qiagen的股東卻下跌了3.9%。但是,請記住,即使是最好的股票有時也會在十二個月內表現不如市場。好的一面是,長期股東賺了錢,在過去的五年中,每年增長3%。最近的拋售可能是一個機會,因此可能值得查看基本面數據以尋找長期增長趨勢的跡象。如果你想更詳細地研究Qiagen,那麼你可能需要看看內部人士是否在買入或賣出該公司的股票。

We will like Qiagen better if we see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

如果我們看到一些重大的內幕收購,我們會更喜歡Qiagen。在我們等待的同時,請查看這份免費清單,列出了最近有大量內幕收購的成長型公司。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

請注意,本文引用的市場回報反映了目前在美國交易所交易的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論